Abstract
Background: Human parvovirus B19 is a global and common infectious pathogen in humans, particularly in children. Objectives: To assess the immunoglobulin G seroprevalence of B19 in children in Israel. Methods: Overall, 128 previously healthy children (1.5-17years old) hospitalized for various diseases other than acute human parvovirus B19 infection were assessed for IgG to the virus by enzyme-linked immunosorbent assay. Results: The IgG seroprevalence increased from 22% in children aged 1.5-9 years to 52% in older children (P = 0.001). conclusions: Our data suggest that most acute parvovirus B19 infections in Israel occur in the early school years, and that by 18 years of age 50% of Israeli children have been infected by the virus.
| Original language | English |
|---|---|
| Pages (from-to) | 277-278 |
| Number of pages | 2 |
| Journal | Israel Medical Association Journal |
| Volume | 12 |
| Issue number | 5 |
| State | Published - May 2010 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Child
- Immunoglobulin G
- Parvovirus B19
- Seroprevalence
Fingerprint
Dive into the research topics of 'Age-related immunoglobulin G seroprevalence of human parvovirus B-19 in Israeli children'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver